Table 1 Baseline characteristics of hospitalized and ambulatory COVID-19 patients.
COVID-19 patient characteristics | Hospitalized (n = 26) | Ambulatory (n = 16) | p-value |
|---|---|---|---|
Median age in years (range) | 62 (21–91) | 43 (18–63) | < 0.001 |
Male (n) (%) | 16 (62%) | 7 (44%) | 0.272 |
Median blood pressure (systolic/diastolic) | 133/78 | 143/92 | 0.073 |
Median respiratory rate (breaths/min.) (SD) | 20 (± 3.2) | 18 (± 3.1) | 0.095 |
Median heart rate (beats per minute) (SD) | 81 (± 10.7) | 71 (± 18.0) | 0.105 |
Geometric mean (range min.–max.) | |||
Leucocytes (n/µL) | 4219 (3230–12,300) | NA | |
Neutrophils (%) | 55 (36–82) | NA | |
Lymphocytes (%) | 19 (8–49) | NA | |
Monocytes (%) | 7 (2–14) | NA | |
Eosinophils (%) | 1 (0–4) | NA | |
Basophils (%) | 0.5 (0.1–1) | NA | |
Erythrocytes (Mio/µL) | 4 (3–6) | NA | |
Hematocrit (%) | 33 (28–47) | NA | |
Hb (g/dL) | 11.5 (8–16) | NA | |
Thrombocytes (1000/µL) | 182 (105–572) | NA | |
*Fibrinogen (mg/dL) | 21 (211–768) | NA | |
Procalcitonin (ng/mL) | 0.07 (0.01–3) | NA | |
Creatine kinase (U/L) | 46 (19–2468) | NA | |
AST (U/L) | 18 (16–748) | NA | |
ALT (U/L) | 20 (9–401) | NA | |
LDH (U/L) | 181 (153–899) | NA | |
